US2005196837A1PendingUtilityA1

Artificial mammalian chromosome

Priority: Jun 7, 1995Filed: Oct 26, 2004Published: Sep 8, 2005
Est. expiryJun 7, 2015(expired)· nominal 20-yr term from priority
C12N 2800/204C12N 15/90C12N 2800/208C12N 15/85C12N 15/66
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to the field of gene therapy, gene expression, and vectors for these uses. In particular, the invention relates to the development and use of an artificial or synthetic chromosome for gene expression and gene therapy in mammals, and especially humans. The invention allows the controlled construction of stable synthetic or artificial chromosomes constructed from isolated segments of purified DNA. Functional minimal segments preferably include centromeric DNA, telomeric DNA, and genomic DNA. The artificial chromosome performs the essential chromosomal functions of naturally-occurring chromosomes so as to permit the chromosome to function as an effective vector for gene therapy.

Claims

exact text as granted — not AI-modified
1 . An artificial mammalian chromosome comprising essentially centromeric, telomeric, and genomic DNA.  
     
     
         2 . An artificial mammalian chromosome comprising essentially centromeric DNA, telomeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments.  
     
     
         3 . An artificial mammalian chromosome comprising essentially centromeric DNA, telomeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments, said centromeric DNA comprises a DNA sequence that associates with CENP-E during mitosis, and said telomeric DNA comprises tandem repeats of the sequence TTAGGG.  
     
     
         4 . An artificial mammalian chromosome produced by the process of transfecting a mammalian cell with purified DNA, said DNA comprising essentially telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments.  
     
     
         5 . An artificial mammalian chromosome produced by the process of transfecting a mammalian cell with purified DNA, said DNA comprising essentially telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments, said centromeric DNA comprises a DNA sequence that associates with CENP-E during mitosis, and said telomeric DNA comprises tandem repeats of the sequence TTAGGG.  
     
     
         6 . An artificial mammalian chromosome produced by the process of transfecting a mammalian cell with purified naked DNA, said DNA comprising essentially telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments.  
     
     
         7 . An artificial mammalian chromosome produced by the process of transfecting a mammalian cell with purified naked DNA, said DNA comprising essentially telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments, said centromeric DNA comprises a DNA sequence that associates with CENP-E during mitosis, and said telomeric DNA comprises tandem repeats of the sequence TTAGGG.  
     
     
         8 . An artificial mammalian chromosome produced by the process of transfecting a mammalian cell with purified condensed DNA, said DNA comprising essentially telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments.  
     
     
         9 . An artificial mammalian chromosome produced by the process of transfecting a mammalian cell with purified condensed DNA, said DNA comprising essentially telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments, said centromeric DNA comprises a DNA sequence that associates with CENP-E during mitosis, and said telomeric DNA comprises tandem repeats of the sequence TTAGGG.  
     
     
         10 . An artificial mammalian chromosome produced by the process of transfecting purified coated DNA into a mammalian cell, said DNA comprising essentially a centromere, a telomere, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments.  
     
     
         11 . An artificial mammalian chromosome produced by the process of transfecting purified coated DNA into a mammalian cell; said DNA comprising essentially a centromere, a telomere, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments, said centromere comprises a DNA sequence that associates with CENP-E during mitosis, and said telomere comprises tandem repeats of the sequence TTAGGG.  
     
     
         12 . The artificial mammalian chromosome of any of claims  4 - 11 , wherein said centromeric DNA, said telomeric DNA and said genomic DNA are not ligated to each other.  
     
     
         13 . The artificial mammalian chromosome of any of claims  4 - 11 , wherein one or more of said centromeric DNA, said telomeric DNA and said genomic DNA are ligated to one another.  
     
     
         14 . A composition comprising the artificial mammalian chromosome of any of claims  1 - 11 .  
     
     
         15 . The artificial mammalian chromosome of any of claims  1 - 11 , wherein said centromeric DNA comprises alpha-satellite DNA.  
     
     
         16 . A mammalian cell comprising the artificial mammalian chromosome of any of claims  1 - 11 .  
     
     
         17 . The artificial mammalian chromosome of any of claims  1 - 11 , wherein said chromosome further comprises a heterologous DNA that is expressed from said chromosome, or causes expression of a gene product, when said chromosome is introduced into a mammalian cell.  
     
     
         18 . Purified DNA comprising essentially telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments.  
     
     
         19 . Purified DNA comprising essentially telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments, said centromeric DNA comprises a DNA sequence that associates with CENP-E during mitosis, and said telomeric DNA comprises tandem repeats of the sequence TTAGGG.  
     
     
         20 . Purified naked DNA comprising essentially telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments.  
     
     
         21 . Purified naked DNA comprising essentially telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments, said centromeric DNA comprises a DNA sequence that associates with CENP-E during mitosis, and said telomeric DNA comprises tandem repeats of the sequence TTAGGG.  
     
     
         22 . Purified condensed DNA comprising essentially telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments, wherein Said DNA is coated with a DNA-condensing agent.  
     
     
         23 . Purified condensed DNA comprising essentially telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments, said centromeric DNA comprises a DNA sequence that associates with CENP-E during mitosis, and said telomeric DNA comprises tandem repeats of the sequence TTAGGG, wherein said DNA is combined with a DNA-condensing agent.  
     
     
         24 . Purified coated DNA comprising essentially telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments, wherein said DNA is coated with one or more DNA-binding proteins.  
     
     
         25 . Purified coated DNA comprising essentially telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments, said centromeric DNA comprises a DNA sequence that associates with CENP-E during mitosis, and said telomeric DNA comprises tandem repeats of the sequence TTAGGG, wherein said DNA is coated with one or more DNA-binding proteins.  
     
     
         26 . Purified DNA made by the process of combining, in vitro, telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments.  
     
     
         27 . Purified DNA made by the process of combining, in vitro, telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments, said centromeric DNA associates with CENP-E during mitosis, and said telomeric DNA comprises tandem repeats of the sequence TTAGGG.  
     
     
         28 . Purified naked DNA made by the process of combining, in vitro, telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments.  
     
     
         29 . Purified naked DNA made by the process of combining, in vitro, telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments, said centromeric DNA associates with CENP-E during mitosis, and said telomeric DNA comprises tandem repeats of the sequence TTAGGG.  
     
     
         30 . Purified condensed DNA made by the process of combining, in vitro, telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments, wherein said DNA is combined with a DNA-condensing agent.  
     
     
         31 . Purified condensed DNA made by the process of combining, in vitro, telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments, said centromeric DNA associates with CENP-E during mitosis, and said telomeric DNA comprises tandem repeats of the sequence TTAGGG, wherein said DNA is combined with a DNA condensing agent.  
     
     
         32 . Purified coated DNA made by the process of combining, in vitro, telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments, wherein said DNA is coated with one or more DNA-binding proteins.  
     
     
         33 . Purified coated DNA made by the process of combining, in vitro, telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments, said centromeric DNA associates with CENP-E during mitosis, and said telomeric DNA comprises tandem repeats of the sequence TTAGGG, wherein said DNA is coated with one or more DNA-binding proteins.  
     
     
         34 . A composition comprising the DNA of any of claims  18 - 33 .  
     
     
         35 . A mammalian cell comprising the purified DNA of any of claims  18 - 33 .  
     
     
         36 . The purified DNA of any of claims  18 - 33 , wherein said centromeric DNA, said telomeric DNA and said genomic DNA are not ligated to each other.  
     
     
         37 . The purified DNA of any of claims  18 - 33 , wherein one or more of said centromeric DNA, said telomeric DNA and said genomic DNA are ligated to each other.  
     
     
         38 . The purified DNA of any of claims  18 - 33 , wherein said centromeric DNA comprises alpha-satellite DNA.  
     
     
         39 . The purified DNA of any of claims  18 - 33 , wherein said DNA further comprises heterologous DNA that is expressed from said chromosome, or causes expression of a gene product, when said DNA is introduced into a mammalian cell.  
     
     
         40 . A vector comprising the DNA of any of claims  18 - 33 .  
     
     
         41 . A cell comprising the vector of  claim 40 .  
     
     
         42 . A composition comprising the vector of  claim 40 .  
     
     
         43 . A method of making an artificial mammalian chromosome, said method comprising introducing the purified DNA of any of claims  18 - 33  into a mammalian cell.  
     
     
         44 . A method of making an artificial mammalian chromosome, said method comprising introducing the composition of  claim 34  into a mammalian cell.  
     
     
         45 . A method of making a purified DNA composition, said method comprising combining, in vitro, purified telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments.  
     
     
         46 . A method of making a purified DNA composition, said method comprising combining, in vitro, purified telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments, said centromeric DNA comprises a DNA sequence that associates with CENP-E during mitosis, and said telomeric DNA comprises tandem repeats of the sequence TTAGGG.  
     
     
         47 . A method of making a purified naked DNA composition, said method comprising combining, in vitro, purified telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments.  
     
     
         48 . A method of making a purified naked DNA composition, said method comprising combining, in vitro, purified telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments, said centromeric DNA comprises a DNA sequence that associates with CENP-E during mitosis, and said telomeric DNA comprises tandem repeats of the sequence TTAGGG.  
     
     
         49 . A method of making a purified condensed DNA composition, said method comprising combining, in vitro, a DNA-condensing agent and purified telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments.  
     
     
         50 . A method of making a purified condensed DNA composition, said method comprising combining, in vitro, a DNA-condensing agent and purified telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments, said centromeric DNA comprises a DNA sequence that associates with CENP-E during mitosis, and said telomeric DNA comprises tandem repeats of the sequence TTAGGG.  
     
     
         51 . A method of making a purified coated DNA composition, said method comprising combining, in vitro, one or more DNA-binding proteins and purified telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments.  
     
     
         52 . A method of making a purified coated DNA composition, said method comprising combining, in vitro, one or more DNA-binding proteins and purified telomeric DNA, centromeric DNA, and genomic DNA, wherein said genomic DNA is a sub-genomic DNA fragment selected from the group consisting of restriction enzyme digestion fragments and mechanically-sheared fragments, said centromeric DNA comprises a DNA sequence that associates with CENP-E during mitosis, and said telomeric DNA comprises tandem repeats of the sequence TTAGGG.  
     
     
         53 . The method of any of claims  43 - 52 , wherein said centromeric DNA, said telomeric DNA and said genomic DNA are not ligated to each other.  
     
     
         54 . The method of any of claims  43 - 52 , wherein one or more of said centromeric DNA, said telomeric DNA and said genomic DNA are ligated to each other.  
     
     
         55 . A method of expressing a gene in a mammalian cell, said method comprising propagating a mammalian cell containing the artificial chromosome of any of claims  1 - 11 , wherein said chromosome contains said gene or contains a DNA sequence that allows expression of said gene.  
     
     
         56 . A method of expressing a heterologous gene in a mammalian cell, said method comprising propagating a mammalian cell containing the DNA of any of claims  18 - 33 , wherein said DNA contains said gene or contains a DNA sequence that allows expression of said gene.  
     
     
         57 . The method of  claim 55 , wherein said gene expression provides a therapeutic benefit to a mammal comprising said cell.  
     
     
         58 . The method of  claim 56 , wherein said gene expression provides a therapeutic benefit to a mammal comprising said cell.

Join the waitlist — get patent alerts

Track US2005196837A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.